An Investigational New Drug (IND) application is submitted to the FDA to obtain permission to start clinical trials for a new drug. This step is crucial in the development of new cancer treatments. The IND application includes data on the drug's composition, manufacturing, and preclinical testing to demonstrate its safety and potential efficacy.
